Clinical Trial Update: A Study of Single Dose of LP-003 in Adolescent Subjects [Phase 1, Phase 2]

View source ↗

Summary

This document reports a Phase 1/2 clinical trial evaluating a single-dose regimen of LP-003 in adolescent subjects with allergic diseases, sponsored by Longbio …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Diseases

Drugs mentioned

• LP-003

Snippet

Sponsor: Longbio Pharma | Conditions: Allergic Diseases | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING